Related Experiment Videos
Immunoscintigraphy in primary colorectal cancer
1Department of Radiology, Nuclear Medicine, University of Chicago, IL 60637.
Cancer
|June 15, 1993
Summary
Immunoscintigraphy, a nuclear medicine technique using radiolabeled antibodies, shows promise for detecting colorectal cancer spread. Further research is needed to define its exact role in staging and patient management.
Area of Science:
- Nuclear Medicine
- Oncology
- Diagnostic Imaging
Background:
- Immunoscintigraphy utilizes radiolabeled antibodies to target tumor-associated antigens for imaging.
- It has been used to visualize primary tumors, lymph node metastases, and distant metastases in colorectal cancer patients.
Purpose of the Study:
- To evaluate the diagnostic utility and precise role of immunoscintigraphy in colorectal cancer.
- To determine if immunoscintigraphy aids in detecting occult disease and altering clinical staging.
Main Methods:
- The study reviews the application of immunoscintigraphy in imaging colorectal cancer.
- It compares immunoscintigraphy with computed tomography (CT) scanning for abdominal and pelvic evaluation.
Main Results:
- Immunoscintigraphy can image primary tumors, regional lymph node metastases, and distant metastases.
- It offers serial whole-body imaging for detecting distant spread, complementing CT scans.
Conclusions:
- The clinical utility of immunoscintigraphy for colorectal cancer is under investigation.
- Its routine preoperative use is debated; further studies are required to establish its role in staging all patients versus selected high-risk individuals.